MXPA03002478A - Compuestos heteroaromaticos biciclicos. - Google Patents

Compuestos heteroaromaticos biciclicos.

Info

Publication number
MXPA03002478A
MXPA03002478A MXPA03002478A MXPA03002478A MXPA03002478A MX PA03002478 A MXPA03002478 A MX PA03002478A MX PA03002478 A MXPA03002478 A MX PA03002478A MX PA03002478 A MXPA03002478 A MX PA03002478A MX PA03002478 A MXPA03002478 A MX PA03002478A
Authority
MX
Mexico
Prior art keywords
bicyclic heteroaromatic
heteroaryl
aryl
heteroaromatic compounds
heterocycloalkyl
Prior art date
Application number
MXPA03002478A
Other languages
English (en)
Inventor
Cornelis Marius Timmers
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of MXPA03002478A publication Critical patent/MXPA03002478A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un compuesto heteroaromatico biciclico de acuerdo con la formula general (l), o una sal farmaceuticamente aceptable del mismo, en donde R1 es (3-8C)cicloalquilo, (2-7C)heterocicloalquilo, (6-14C)arilo o (4-13C)heteroarilo; todos opcionalmente substituidos con uno o mas substituyentes; R2 es (1-4C)alquilo, (2-4C)alqueniloI (2-4C)alquinilo, (6- 14C)arilo o (4-13C)heteroarilo; R3 es (1-8C)alquilo, (3-8C)cicloalquilo, (2-7C)heterocicloalquilo, (6-14C)arilo o (4-13C)heteroarilo; Y es CH o N; Z es NH2 u OH; A es S, N(H), N(R), O o un enlace y B es N(H), O o un enlace; X1-X2 es C=C, C(O)-NH, NH-C(O), C(O)-O, O-C(O), C=N, N=C o S u O. Los compuestos de la invencion pueden usarse en terapias de regulacion de fertilidad.
MXPA03002478A 2000-09-22 2001-09-17 Compuestos heteroaromaticos biciclicos. MXPA03002478A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00203287 2000-09-22
PCT/EP2001/010743 WO2002024703A1 (en) 2000-09-22 2001-09-17 Bicyclic heteroaromatic compounds

Publications (1)

Publication Number Publication Date
MXPA03002478A true MXPA03002478A (es) 2004-05-05

Family

ID=8172046

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03002478A MXPA03002478A (es) 2000-09-22 2001-09-17 Compuestos heteroaromaticos biciclicos.

Country Status (32)

Country Link
US (2) US7229990B2 (es)
EP (2) EP1886999A3 (es)
JP (1) JP4977940B2 (es)
KR (1) KR100860040B1 (es)
CN (1) CN1247594C (es)
AR (1) AR030784A1 (es)
AT (1) ATE384726T1 (es)
AU (2) AU2002213929B2 (es)
BR (1) BR0113987A (es)
CA (1) CA2422054C (es)
CY (1) CY1107308T1 (es)
CZ (1) CZ297136B6 (es)
DE (1) DE60132607T2 (es)
DK (1) DK1322651T3 (es)
EC (1) ECSP034523A (es)
ES (1) ES2299524T3 (es)
HK (1) HK1054942A1 (es)
HR (1) HRP20030220B1 (es)
HU (1) HU229422B1 (es)
IL (2) IL154624A0 (es)
IS (1) IS2531B (es)
MX (1) MXPA03002478A (es)
NO (1) NO328683B1 (es)
NZ (1) NZ524444A (es)
PE (1) PE20020537A1 (es)
PL (1) PL207755B1 (es)
PT (1) PT1322651E (es)
RU (1) RU2271360C2 (es)
SK (1) SK287554B6 (es)
TW (1) TWI290143B (es)
WO (1) WO2002024703A1 (es)
ZA (1) ZA200301588B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60132607T2 (de) * 2000-09-22 2009-01-29 N.V. Organon Bicyclische heteroaromatische verbindungen
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
US7723342B2 (en) * 2005-05-17 2010-05-25 Schering Corporation Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
WO2007136776A2 (en) * 2006-05-17 2007-11-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pyrimidine low molecular weight ligands for modulating hormone receptors
JP5302389B2 (ja) 2008-04-29 2013-10-02 エフ.ホフマン−ラ ロシュ アーゲー Jnkのピリミジニルピリドンインヒビター
WO2010047674A1 (en) 2008-10-20 2010-04-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
CA2789818A1 (en) 2010-04-08 2011-10-13 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Inverse agonists and neutral antagonists for the tsh receptor
FI3392252T3 (fi) * 2011-08-23 2024-01-08 Libertas Bio Inc Pyrimidopyridazinoniyhdisteet ja niiden käyttö
CN113680386B (zh) * 2021-08-23 2023-08-11 深圳湾实验室坪山生物医药研发转化中心 氮杂环卡宾-方酰胺双功能催化剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0765327B1 (en) * 1994-06-16 1999-07-21 Pfizer Inc. Pyrazolo and pyrrolopyridines
CA2254974A1 (en) * 1996-05-20 1997-11-27 Mark Goulet Antagonists of gonadotropin releasing hormone
TW564247B (en) * 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound
DE60132607T2 (de) * 2000-09-22 2009-01-29 N.V. Organon Bicyclische heteroaromatische verbindungen

Also Published As

Publication number Publication date
KR20030040483A (ko) 2003-05-22
HU229422B1 (hu) 2013-12-30
DE60132607T2 (de) 2009-01-29
US7618963B2 (en) 2009-11-17
DE60132607D1 (de) 2008-03-13
HUP0302648A2 (hu) 2003-11-28
IL154624A (en) 2009-09-01
EP1322651B1 (en) 2008-01-23
ECSP034523A (es) 2003-04-25
PL360675A1 (en) 2004-09-20
AU2002213929B2 (en) 2006-04-13
CA2422054C (en) 2011-01-11
ES2299524T3 (es) 2008-06-01
WO2002024703A1 (en) 2002-03-28
PE20020537A1 (es) 2002-06-20
CY1107308T1 (el) 2012-11-21
EP1886999A2 (en) 2008-02-13
SK3312003A3 (en) 2003-08-05
CN1247594C (zh) 2006-03-29
US20030225113A1 (en) 2003-12-04
EP1886999A3 (en) 2008-03-12
JP4977940B2 (ja) 2012-07-18
DK1322651T3 (da) 2008-06-02
NO20031314D0 (no) 2003-03-21
KR100860040B1 (ko) 2008-09-25
TWI290143B (en) 2007-11-21
PL207755B1 (pl) 2011-01-31
HUP0302648A3 (en) 2004-11-29
IL154624A0 (en) 2003-09-17
EP1886999A8 (en) 2010-08-04
HRP20030220A2 (en) 2003-06-30
CZ297136B6 (cs) 2006-09-13
CN1462273A (zh) 2003-12-17
HK1054942A1 (en) 2003-12-19
NZ524444A (en) 2004-03-26
US20070197527A1 (en) 2007-08-23
RU2271360C2 (ru) 2006-03-10
ATE384726T1 (de) 2008-02-15
ZA200301588B (en) 2004-06-22
IS6732A (is) 2003-02-28
SK287554B6 (sk) 2011-01-04
AR030784A1 (es) 2003-09-03
CZ2003828A3 (cs) 2003-08-13
PT1322651E (pt) 2008-02-28
EP1322651A1 (en) 2003-07-02
IS2531B (is) 2009-07-15
JP2004509896A (ja) 2004-04-02
BR0113987A (pt) 2003-08-12
NO20031314L (no) 2003-03-21
US7229990B2 (en) 2007-06-12
CA2422054A1 (en) 2002-03-28
HRP20030220B1 (en) 2011-10-31
NO328683B1 (no) 2010-04-26
AU1392902A (en) 2002-04-02

Similar Documents

Publication Publication Date Title
MXPA03002478A (es) Compuestos heteroaromaticos biciclicos.
EP1375472A4 (en) BENZENE COMPOUND AND SALT THEREOF
AP1965A (en) Tropane derivatives useful in therapy.
MXPA04004037A (es) Compuestos novedosos de 1, 2, 4-de triazol.
CA2368834A1 (en) Bicyclic heteroaromatic compounds useful as lh agonists
CA2094335A1 (en) 4,1-benzoxazepin derivatives and their use
CA2359646A1 (en) Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-.beta.-cyclodextrin or 2-hydroxypropyl-.beta.-cyclodextrin and method
UA86031C2 (ru) Применение скопинового эфира как исходного материала для получения соединений, которые проявляют терапевтическое действие
GB0324269D0 (en) EP4 receptor antagonists
WO2003035620A1 (fr) Compose bicyclique
EP1284266A4 (en) NEW INDOIND DERIVATIVES WITH CHYME-INHIBITABLE ACTIVITIES AND METHOD FOR THEIR PREPARATION
MXPA04009476A (es) Compuestos de (tiazol-4,2-disustituidos-5-il)amina como inhibidores de la pde7.
WO2003029218A1 (fr) Compose azote et utilisation correspondante
WO1999009965A3 (en) Anti-inflammatory agent
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.
MXPA04000978A (es) Procedimiento para la produccion de 4-amino-2,5-bisheterociclilquinazolinas.
MXPA03011032A (es) Activadores de derivados de oxazol/tiazol del receptor hppar-alfa.
HK1054388A1 (en) Process for preparing a substituted imidazopyridine compound.
EP1637526A4 (en) CURABLE, POLYCYCLIC COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
EP1310490A4 (en) GPR14 ANTAGONIST
GB1290145A (es)
BG106048A (en) 6-[[(aryl and heteroaryl)oxy]methyl]naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
SI1572198T1 (sl) Nove farmacevtske spojine z alfa2 receptorsko aktivnostjo
EP1650199A4 (en) SULPHONAMIDE DERIVATIVE WITH ISOXAZOL RING
EP1142892A4 (en) METHOD FOR PRODUCING NEW NAPHTYRIDINE DERIVATIVES

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights
GB Transfer or rights
GB Transfer or rights